| Catalog No. |
TD-HX913016 |
| Species reactivity |
Human |
| Applications |
Research Grade Biosimilar |
| Host species |
Human |
| Isotype |
IgG4-kappa |
| Expression system |
Mammalian Cells |
| Clonality |
Monoclonal |
| Target |
IL13R, IL-13R subunit alpha-1, IL13RA1, IL13RA, IL-13RA1, CD213a1, Interleukin-13 receptor subunit alpha-1, IL-13 receptor subunit alpha-1, CT19, IL-13R-alpha-1, Cancer/testis antigen 19 |
| Endotoxin level |
Please contact the lab for this information. |
| Purity |
>95% purity as determined by SDS-PAGE. |
| Purification |
Protein A/G, purified from cell culture supernatant. |
| Accession |
P78552 |
| Form |
Liquid |
| Storage buffer |
0.01M PBS,pH7.4. |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names |
ASLAN-004,ASLAN004,CSL-334CAS:2445460-16-0 |
| Background |
Eblasakimab (ASLAN004; CSL-334) is a human IgG4 antibody that specifically targets IL13RA1 and is primarily expressed by CHO-K1 cells. |
| Note |
For research use only. Not for use in clinical or therapeutic applications. |